FullCircle Wealth’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$702K Buy
2,217
+3
+0.1% +$933 0.25% 124
2025
Q2
$609K Buy
2,214
+530
+31% +$213K 0.23% 128
2025
Q1
$697K Buy
1,684
+1
+0.1% +$401 0.29% 114
2024
Q4
$659K Sell
1,683
-60
-3% -$25.1K 0.27% 111
2024
Q3
$727K Buy
1,743
+26
+2% +$13.9K 0.33% 99
2024
Q2
$879K Buy
+1,717
New +$908K 0.43% 79

Other funds holding ELV

FullCircle Wealth's ELV Position: Q3 2025 in Review

FullCircle Wealth increased its Elevance Health (ELV) stake by 0.14% in Q3 2025, buying an estimated $933 and bringing the position to 2,217 shares worth $702K. The position accounts for 0.25% of the portfolio, ranked #124.

FullCircle Wealth first reported a position in ELV in Q2 2024 and has held it in 6 quarters since. The position peaked at $879K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • FullCircle Wealth held 2,217 shares of Elevance Health worth $702K as of Q3 2025.
  • FullCircle Wealth bought 3 Elevance Health shares in Q3 2025, an estimated $933.
  • Elevance Health made up 0.25% of FullCircle Wealth's portfolio in Q3 2025, its #124 holding.
  • FullCircle Wealth first reported a position in Elevance Health in Q2 2024 and has held it in 6 quarters since.
  • FullCircle Wealth's Elevance Health position peaked at $879K in Q2 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on FullCircle Wealth's 13F filing for Q3 2025, filed 5 Nov 2025.